Anders Martin-Löf
Director of Finance/CFO at BIOARCTIC AB
Net worth: 15 197 $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lars Gunnar Lannfelt | M | 75 | 21 years | |
Pär Lars Gellerfors | M | 77 | 21 years | |
Sofia Heigis | F | 44 | 4 years | |
Thoas Michael Fioretos | M | 66 | 15 years | |
Eugen Steiner | M | 70 | 7 years | |
Göran Forsberg | M | 61 | 10 years | |
Karolina Vilval | F | 45 |
Oncopeptides Incentive AB
| 3 years |
Patricia Delaite | M | 61 | 7 years | |
Flavia Borellini | M | 65 | 4 years | |
Karin Leandersson | F | 52 | 8 years | |
Bengt Håkan Englund | M | 72 | 4 years | |
Gunilla Christina Osswald | M | 63 | 11 years | |
Jan Mattsson | M | 64 | 7 years | |
Jennifer Jackson | M | 71 | 6 years | |
Joachim Feldwisch | M | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Lennart Rolf Ivar Verner | M | 77 | 14 years | |
Martin Duvall | M | 62 |
Oncopeptides Incentive AB
| 2 years |
Oskar Bosson | M | 48 | 4 years | |
Åke Mikael Smedeby | M | 56 | 6 years | |
Gunnar Magnus Modee Persson | M | 64 | 8 years | |
Stig Anders Lindberg | M | 52 |
Oncopeptides Incentive AB
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Karin Nord | M | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 years |
Carl Erik Mathias Uhlén | M | 70 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 years |
Charlotta Ljungqvist | M | 63 | 3 years | |
Damian Marron | M | 62 | 3 years | |
Magnus Nilsson | M | 68 | 3 years | |
Anna-Kaija Grönblad | F | 56 | 3 years | |
Camilla Soenderby | F | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Lotta Larsson | F | - | 14 years | |
Gunilla Andersson | F | 63 | 5 years | |
David Liberg | M | 55 | 9 years | |
Johanna Fälting | M | 52 | 12 years | |
Patrik Renblad | M | 54 | 1 years | |
Lars Thorsson | M | 63 | 9 years | |
Liselotte Larsson | M | 61 | 10 years | |
Lars Jordeby | M | 59 | 10 years | |
Alan Hulme | M | - |
Oncopeptides Incentive AB
| - |
David Bejker | M | 49 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 6 years |
Robert Forbes Burns | M | 77 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Dominique Tersago | M | 62 | 2 years | |
Tomas Odergren | M | 65 | 5 years | |
Peter Kemlin | M | 50 | 12 years | |
Cecilia Marie Edström | F | 58 | 1 years | |
Jose F. Suarez | M | 54 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Nedjad Losic | M | 54 | 3 years | |
Christer Möller | M | 65 | 18 years | |
J. Kenneth Charles Knowles | M | 77 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Wenche Nelly A. Rolfsen Sandsborg | M | 72 | 7 years | |
Rolf Gulliksen | M | 65 | 3 years | |
Peter Thysell | M | 54 | 6 years | |
Victoria Sörving | F | 38 | - | |
Johan Georg Harmenberg | M | 70 | 7 years | |
Klaas Bakker | M | 42 | - | |
Roger Belusa | M | - | - | |
Susanne Lagerlund | F | 56 | 3 years | |
Peter Juul Madsen | M | - | 2 years | |
Ignacio Garcia-Ribas | M | - | 2 years | |
Karin Eklund Vanderpol | F | 51 | 2 years | |
Linda Holmström | F | - | - | |
Corinne Savill | M | 64 | - | |
Christian Jacques | M | 68 | 2 years | |
Elisabeth Augustsson | F | 59 | 5 years | |
Bengt Jöndell | M | 64 | 6 years | |
Annika Muskantor | F | 58 | 2 years | |
Karin Birgitta Margareta Ståhl | F | 53 | 2 years | |
Claus Asbjørn Andersson | M | 56 | 8 years | |
Rein Piir | M | 66 | 4 years | |
Han Jing Xie | M | 54 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 68 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anders Martin-Löf
- Personal Network